InvestSMART

Adherium Limited (ASX:ADR)

ALERT: Price-sensitive ASX Announcement for ADR
Current share price for ADR : $0.100 -0.005 (-4.76%)+
Announcement
Release
29 Jul 2026 12:06PM
Price at Release
$0.105
Full Release
download
Summary
Adherium Limited, a leader in digital respiratory management, announced the transition of leadership as CEO Dawn Bitz steps down for personal reasons. John Perry, the current Chief Commercial Officer, will assume the role of Interim CEO. The transition aims to ensure leadership continuity as Adherium continues to expand its Remote Patient Monitoring and Value Based Care initiatives. The board acknowledges Dawn's significant contributions over the past year, including the growth of the Hailie® platform and establishing the Remote Patient Monitoring channel. John Perry, with his extensive experience in healthcare leadership and strategic planning, is expected to lead the company towards further growth.
Key Points
  • CEO Dawn Bitz steps down for personal reasons.
  • John Perry appointed as Interim CEO.
  • Continued focus on Remote Patient Monitoring and Value Based Care.
  • Recognition of Dawn Bitz's contributions to the company's progress.
  • John Perry's expertise in healthcare leadership to guide the company's growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.